This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Obagi Medical Products And Suneva Medical Partner To Offer ReGenica® Facial Rejuvenation Complex

Stocks in this article: OMPI

Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin-health systems, and Suneva Medical, Inc., a rapidly growing aesthetics company, jointly announce a partnership to co-distribute ReGenica Facial Rejuvenation Complex.

This technologically advanced product supports a more rapid improvement in the appearance of post-laser skin by fusing the promise of stem cells with the power of growth factors. It has been clinically proven to accelerate the return of healthy appearing skin after a combination ablative/nonablative laser treatment compared to a vehicle control in two separate studies published in peer-reviewed journals 1,2. Obagi is extremely pleased to be co-distributing the ReGenica Facial Rejuvenation Complex, along with the Suneva sales force. It can now offer a clinically proven post-procedure solution to its physicians and their patients.

ReGenica's secret lies in its Multipotent CCM Complex (Cell Conditioned Media) developed by Dr. Gail K. Naughton, a renowned pioneer in the field of regenerative medicine. CCM is a highly potent composition of active growth factors and proteins not found in any other skincare product and developed through a revolutionary and highly proprietary scientific method. Only ReGenica contains this breakthrough, bovine serum-free, multipotent CCM in an innovative formulation optimized with the most advanced cosmeceutical skin conditioning agents.

“Obagi is delighted to offer another revolutionary skincare solution to patients. The addition of the ReGenica line solidifies already existing evidence that Obagi is dedicated to delivering the most efficacious, innovative products to patients seeking real solutions,” Al Hummel, Obagi’s President and CEO, said. “The Facial Rejuvenation Complex addresses the need for post-procedure skincare treatments that are not only gentle and safe for compromised skin, but also accelerate the visible improvement in the appearance of side effects associated with procedures.”

“Obagi has significant expertise and a proven track record of marketing physician-dispensed products. We believe this relationship will accelerate our penetration in the marketplace and bring ReGenica Facial Rejuvenation Complex to more physicians in need of a cutting edge post-procedure solution and are excited to have a company as successful as Obagi as our partner,” commented Nicholas Teti, Chairman and Chief Executive Officer of Suneva Medical.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs